Gene · 55215
Papers1,818
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,818
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR/Cas9-based genome-wide screen reveals a synergistic effect of Irinotecan and USP1 inhibitor in colorectal cancer. | Eur J Pharmacol | 2026 | 41577322 | PubTator, text mining | PubMed |
| Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis. | Eur J Med Res | 2026 | 41555462 | PubTator, text mining | PubMed |
| Human cytomegalovirus regulates host DNA repair machinery for viral genome integrity. | Nucleic Acids Res | 2026 | 41533576 | PubTator, text mining | PubMed |
| The SMC5/SMC6 complex is critical for resolving R-loop-induced transcription-replication conflicts. | Nucleic Acids Res | 2026 | 41533569 | PubTator, text mining | PubMed |
| The FANCD2-FANCI heterodimer coordinates chromatin openness and cell cycle progression throughout DNA double-strand break repair. | Cell Rep | 2026 | 41505257 | PubTator, text mining | PubMed |
| Betulinic Acid Suppresses UBE2T Expression via MAPK/ERK Inhibition to Block FANCI and FANCD2 Monoubiquitination in Glioblastoma. | J Cell Mol Med | 2026 | 41486508 | PubTator, text mining | PubMed |
| Integrating CRISPR/Cas technology with clinical trials: Principles, progress and challenges. | Asian J Pharm Sci | 2025 | 41809894 | PubTator, text mining | PubMed |
| Ginsenoside Rh2 Suppresses the Fanconi Anemia Pathway by Inhibiting NF-κB-Mediated FANCL Transcription in Bladder Cancer. | Dose Response | 2025 | 41425456 | PubTator, text mining | PubMed |
| TSN Disrupts Fanconi Anemia Pathway Activation Through JAK/STAT1-Mediated Transcriptional Repression of FA Core Subunits in Bladder Cancer. | Dose Response | 2025 | 41346410 | PubTator, text mining | PubMed |
| Piperine Targets the FANCL/UBE2T Complex to Inhibit the FA Pathway and Sensitize Bladder Cancer to Cisplatin. | Dose Response | 2025 | 41306722 | PubTator, text mining | PubMed |
| Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry. | Nat Commun | 2025 | 41038821 | PubTator, text mining | PubMed |
| EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers. | Nat Commun | 2025 | 41006228 | PubTator, text mining | PubMed |
| Olaparib maintenance therapy for recurrent adult granulosa cell tumors: A case report. | J Obstet Gynaecol Res | 2025 | 40974087 | PubTator, text mining | PubMed |
| Head and Neck Cancer in Fanconi Anemia: Clinical Challenges and Molecular Insights into a DNA Repair Disorder. | Cancers (Basel) | 2025 | 40970532 | PubTator, text mining | PubMed |
| Circulating tumor DNA as a marker of molecular residual disease in resected esophageal squamous cell carcinoma. | Mol Biomed | 2025 | 40963072 | PubTator, text mining | PubMed |
| Selumetinib Treatment in a Neurofibromatosis Type 1 Child With Second Hit Mutation on the NF1 Gene. | Int J Dev Neurosci | 2025 | 40891287 | PubTator, text mining | PubMed |
| The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells. | Elife | 2025 | 40878909 | PubTator, text mining | PubMed |
| Potential role of Fanconi anemia pathway in the pathogenesis of endometrial cancer (Review). | Mol Med Rep | 2025 | 40849815 | PubTator, text mining | PubMed |
| Genome-Wide Association Study and Rare Variant Association Studies of Strabismus in the All of Us Research Program. | Ophthalmol Sci | 2025 | 40837069 | PubTator, text mining | PubMed |
| Identification of hypoxia-related diagnostic biomarkers and immune signatures in diminished ovarian reserve. | Front Genet | 2025 | 40832468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55215/papers?page=2